Search results for "Pancreatic neoplasms"

showing 10 items of 191 documents

The Influence of Insulin on Local Amyloidosis of the Islets of Langerhans and Insulinoma

1980

Summary Amyloid-containing islets of Langerhans from the pancreas of 75 diabetics and one case of an amyloid-containing insulinoma were investigated. By light and electron microscopy, amyloid deposits were observed between the B cells and adjacent capillaries. The cytoplasm of B cells and extracellular amyloid display immunohistological binding of anti-insulin antibody. Correspondingly, ferritin-labeled anti-insulin antibody was found by electron microscopy on and between the amyloid fibrils. Insulin or proinsulin (or a protein closely related to insulin) thus appears to be a.component of the protein which constitutes the amyloid. The molecular weight and mode of deposition of this form of …

AdultMalemedicine.medical_specialtyAmyloidmedicine.medical_treatmentPathology and Forensic MedicineIslets of LangerhansInsulin-Secreting CellsInternal medicinemental disordersExtracellularmedicineHumansHypoglycemic AgentsInsulinInsulinomaAgedProinsulinAged 80 and overbiologyChemistryInsulinAmyloidosisAmyloidosisCell BiologyMiddle Agedmedicine.diseaseImmunohistochemistryPancreatic NeoplasmsMicroscopy Electronmedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 2biology.proteinFemaleInsulinomaAntibodyPancreasPathology - Research and Practice
researchProduct

Preoperative diagnostics in pancreatic carcinoma: would less be better?

1998

Objective: The objective of this study was to investigate the value of preoperative diagnostics in patients with pancreatic carcinoma in terms of tumor diagnosis and evaluation of resectability. Patients/Methods: From 1 September 1985 to 31 December 1997, 408 patients shown by histology to have a ductal (n=330) or periampullary carcinoma (n=78) were treated at our hospital. Results: In determining the presence of tumor, ultrasonography and computed tomography (CT) had a sensitivity of 88.3% and 94.0%, respectively; combined, they had a sensitivity of 96.2%. Endoscopic retrograde cholangiopancreatography (ERCP) had a sensitivity of 96.2%. Preoperative aspiration biopsy cytology had a sensiti…

AdultMalemedicine.medical_specialtyCA-19-9 AntigenSensitivity and SpecificityCytologyBiopsymedicineCarcinomaHumansNeoplasm InvasivenessNeoplasm MetastasisLaparoscopyAgedUltrasonographyAged 80 and overCholangiopancreatography Endoscopic RetrogradeEndoscopic retrograde cholangiopancreatographymedicine.diagnostic_testbusiness.industryCarcinomaCarcinoma Ductal BreastMiddle Agedmedicine.diseasePancreatic NeoplasmsAngiographyPancreatitisSurgeryFemaleRadiologybusinessTomography X-Ray ComputedAbdominal surgeryLangenbeck's archives of surgery
researchProduct

Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis.

2011

Background. Liver transplantation (LT) has been accepted as a treatment in selected cases of neuroendocrine tumors (NETs) with hepatic metastases. Patients and Methods. A systematic review of the literature was conducted to evaluate long-term patient survival in the instances of LT for pancreatic NET. Univariate and multivariate regression analyses and survival analysis were performed. Results. Fifty-three clinical studies were screened. Data from 20 studies encompassing 89 transplanted patients were included in the study. Most primary tumors were endocrine pancreatic tumors (n = 69), with gastrinomas representing the most frequent diagnosis (n = 21). There were 61 functioning pancreatic NE…

AdultMalemedicine.medical_specialtyPancreatic diseaseAdolescentmedicine.medical_treatmentPopulationMedizinLiver transplantationNeuroendocrine tumorsGastroenterologyYoung AdultPancreatic tumorInternal medicineCarcinomamedicineHumanseducationChildSurvival analysisRetrospective StudiesTransplantationeducation.field_of_studybusiness.industryLiver NeoplasmsCancerMiddle Agedmedicine.diseasePrognosisSurvival AnalysisCarcinoma NeuroendocrineLiver TransplantationPancreatic NeoplasmsFemalebusinessTransplantation
researchProduct

Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective contro…

2000

Summary Background Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive and increasingly used procedure in cases involving biliary and pancreatic diseases. However, the accuracy of MRCP in differential diagnosis between pancreatic cancer and chronic pancreatitis has never been documented in a large prospective controlled study. Methods 124 patients were recruited for the study, selected from 141 consecutive patients with an average age of 55 years (range 19–80) who presented to our department between February, 1996, and January, 1998, with a strong clinical suspicion of pancreatic cancer. MRCP images were interpreted by a radiologist and a gastroenterologist who were unaware…

AdultMalemedicine.medical_specialtyPancreatic diseaseBiopsySensitivity and SpecificityGastroenterologyPredictive Value of TestsPancreatic cancerInternal medicineBiopsymedicineHumansProspective StudiesAgedAged 80 and overCholangiopancreatography Endoscopic RetrogradeCommon Bile DuctObserver VariationMagnetic resonance cholangiopancreatographyEndoscopic retrograde cholangiopancreatographymedicine.diagnostic_testbusiness.industryBiopsy NeedleCarcinomaPancreatic DuctsGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingPancreatic Neoplasmsmedicine.anatomical_structurePancreatitisChronic DiseaseFeasibility StudiesPancreatitisFemaleRadiologyDifferential diagnosisPancreasbusinessFollow-Up StudiesThe Lancet
researchProduct

Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis

1997

Lysosomal cathepsins D (CD), B (CB), and L (CL) serum levels were determined by immunoassays in patients with chronic (CHP) or acute (AP) pancreatitis and in patients with ductal pancreatic carcinoma (DPC) and correlated with some biological and clinical parameters of this tumor. CB serum concentrations significantly higher than those measured in healthy subjects (NS) were observed in CHP, AP, and DPC patients (p < 0.01). However, no significant difference was noted among these groups. Increased CL serum levels were evident only in cancer patients compared to NS, AP, or CHP groups (p < 0.05), while no difference was observed among these groups. Elevated CD serum values were observed i…

AdultMalemedicine.medical_specialtyPancreatic diseaseCA-19-9 AntigenEndocrinology Diabetes and MetabolismCathepsin LLysosomal proteinaseCathepsin DTumor markers.Cathepsin BEndocrinologyPancreatic cancerInternal medicineEndopeptidasesInternal MedicinemedicineCarcinomaAspartic Acid EndopeptidasesHumansAntigens Tumor-Associated CarbohydrateAgedAged 80 and overVHepatologybusiness.industryCarcinoma Ductal BreastCancerPancreatic cancerMiddle Agedmedicine.diseaseCathepsinsPancreatic NeoplasmsCysteine EndopeptidasesEndocrinologymedicine.anatomical_structurePancreatitisTumor progressionAdenocarcinomaPancreatitisFemalePancreasbusinessLysosomes
researchProduct

Mucinous cystadenomas and intraductal papillary mucinous tumors of the pancreas in magnetic resonance cholangiopancreatography.

2000

Background and Study Aims: In mucin-producing tumors of the pancreas, diagnosis using endoscopic retrograde cholangiopancreatography (ERCP) is limited to cystic formations that communicate with the main pancreatic duct. Magnetic resonance cholangiopancreatography (MRCP) is a new, sophisticated method which is currently under evaluation. The authors describe the usefulness of MRCP in diagnosis of mucin-producing tumors. Patients and Methods: Six patients with mucin-producing tumors were investigated using MRCP and ERCP. Imaging was compared with surgery and histopathological examinations. Results: Three patients were found to have mucinous cystadenomas (MC), two patients had intraductal papi…

AdultMalemedicine.medical_specialtyPancreatic diseaseCholangiographyCystadenoma MucinousmedicineHumansEndoscopy Digestive SystemCystadenocarcinomaMucinous cystadenomaAgedPancreatic ductMagnetic resonance cholangiopancreatographyEndoscopic retrograde cholangiopancreatographymedicine.diagnostic_testbusiness.industryGastroenterologyMiddle Agedmedicine.diseaseMagnetic Resonance ImagingPancreatic Neoplasmsmedicine.anatomical_structureFeasibility StudiesFemaleRadiologyPancreasbusinessCholangiographyEndoscopy
researchProduct

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safet…

2007

Background: In daily clinical practice second-line chemotherapy (SLCT) is frequently given to patients with advanced pancreatic cancer failing gemcitabine-based first-line chemotherapy without solid scientific support. Patients and methods: A retrospective survey was carried out including 42 patients. Patients received standard FOLFOX4 regimen biweekly until progression or unacceptable toxicity. Results: Six partial responses (14%) and 16 stabilizations (38%) were recorded for a tumor growth control rate of 57%. The median time to progression (TtP) was 4 months (range 1–7 months), and median overall survival (OS) was 6.7 months (range 2–9 months). A stabilization of performance status (PS) …

AdultMalemedicine.medical_specialtyPancreatic diseaseOrganoplatinum Compoundsmedicine.medical_treatmentLeucovorinAdenocarcinomaInternal medicinePancreatic cancerAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansAgedRetrospective StudiesChemotherapyPerformance statusbusiness.industryCancerHematologyMiddle Agedmedicine.diseaseChemotherapy regimenGemcitabineDrug Resistance MultipleSurgeryPancreatic NeoplasmsFOLFOX4 regimen pancreatic carcinoma second-line chemotherapyRegimenOncologyChemotherapy AdjuvantDrug Resistance NeoplasmFemaleFluorouracilbusinessmedicine.drug
researchProduct

Total pancreatectomy: indications, operative technique, and results: a single centre experience and review of literature.

2010

The aims of this study were to identify the indications to perform a total pancreatectomy and to evaluate the outcome and quality of life of the patient who underwent this operation. A retrospective analysis of a prospective database, regarding all the patients who underwent total pancreatectomy from January 2006 to June 2009, was carried out. Perioperative and outcome data were analyzed in two different groups: ductal adenocarcinoma (group 1) and non-ductal adenocarcinoma (group 2). Twenty (16.9%) total pancreatectomies out of 118 pancreatic resections were performed. Seven (35.0%) patients were affected by ductal adenocarcinoma (group 1) and the remaining 13 (65.0%) by pancreatic diseases…

AdultMalemedicine.medical_specialtyPancreatic diseaseSURGERYmedicine.medical_treatmentNeuroendocrine tumorsTOTAL PANCREATECTOMYGastroenterologyPancreatectomyPostoperative ComplicationsTUMORPancreatic cancerInternal medicinemedicineHumansAgedPANCREASbusiness.industryPerioperativeMiddle Agedmedicine.diseasePancreaticoduodenectomyPancreatic cancer Pylorus preserving Spleen preservingSurgeryPancreatic NeoplasmsSettore MED/18 - Chirurgia GeneralePancreatectomyCHRONIC PANCREATITISPancreatitisAdenocarcinomaFemalebusinessUpdates in surgery
researchProduct

PANCREATIC CARCINOMA VERSUS CHRONIC FOCAL PANCREATITIS: CONTRAST-ENHANCED POWER DOPPLER ULTRASONOGRAPHY FINDINGS

2005

Background: We assessed the potential usefulness of contrast-enhanced power Doppler ultrasonography (US) for differentiating pancreatic carcinoma from chronic focal pancreatitis. Methods: Twenty-six consecutive patients with ductal carcinoma (n=16) and chronic focal pancreatitis (n=10) underwent power Doppler US examinations before and after intravenous injection of an air-based contrast agent (Levovist, Schering, Berlin, Germany). Final diagnosis was obtained by surgery in all patients. The following parameters before and after intravenous administration of contrast agent were evaluated for each lesion: number, morphology and course of the vessels within the lesion and time to maximum dete…

AdultMalemedicine.medical_specialtyPancreatic diseasechronic focal pancreatitiUrologyContrast MediaAdenocarcinomaDiagnosis DifferentialLesionPolysaccharidesInternal medicinemedicineCarcinomaHumansRadiology Nuclear Medicine and imagingAgedRetrospective Studiespower Doppler ultrasonographyRadiological and Ultrasound Technologypancreatic carcinomabusiness.industryultrasoundUltrasoundGastroenterologyUltrasonography DopplerGeneral MedicineMiddle AgedDuctal carcinomaHepatologymedicine.diseasePancreatic NeoplasmsPancreatitisChronic DiseaseInjections IntravenousPancreatitisFemaleRadiologymedicine.symptombusinessBlood Flow Velocitycontrast-enhanced ultrasoundContrast-enhanced ultrasound
researchProduct

Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States

2016

Objectives Survival improvement for pancreatic cancer has not been observed in the last 4 decades. We report the most up-to-date population-based relative survival (RS) estimates and recent trends in Germany and the United States. Methods Data for patients diagnosed in 1997 to 2010 and followed up to 2010 were drawn from 12 population-based German cancer registries and the US SEER (Surveillance, Epidemiology and End Results) 13 registries database. Using period analysis, 5-year RS for 2007 to 2010 was derived. Model-based period analysis was used to assess 5-year RS time trends, 2002-2010. Results In total 28,977 (Germany) and 34,793 (United States) patients aged 15 to 74 years were analyze…

AdultMalemedicine.medical_specialtyPathologyAdolescentEndocrinology Diabetes and MetabolismPopulationYoung Adult03 medical and health sciencesAge DistributionSex Factors0302 clinical medicineEndocrinologyGermanyPancreatic cancerEpidemiologyInternal MedicineHumansMedicineRegistriesYoung adulteducationSurvival analysisAgedNeoplasm StagingAged 80 and overeducation.field_of_studyHepatologyRelative survivalbusiness.industryAge FactorsCancerMiddle AgedPrognosismedicine.diseaseSurvival AnalysisUnited StatesPancreatic NeoplasmsSurvival Rate030220 oncology & carcinogenesisPeriod AnalysisFemale030211 gastroenterology & hepatologybusinessSEER ProgramDemographyPancreas
researchProduct